{"title":"Novel isatin–triazole based thiosemicarbazones as potential anticancer agents: synthesis, DFT and molecular docking studies","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA01937G","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA01937G\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,14051-14067<br /><b>DOI</b>: 10.1039/D4RA01937G, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png\" alt=\"Creative Commons Licence\" /></a>  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\">Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</a></div><div>Alia Mushtaq, Rabbia Asif, Waqar Ahmed Humayun, Muhammad Moazzam Naseer<br />Synthesis of mono- and bis-thiosemicarbazones <strong>4a–h</strong> and <strong>5a–h</strong> of isatin–triazole hybrids <strong>3a</strong> and <strong>3b</strong> in turn accessed <em>via</em> CuAAC, their DFT studies and potential as phosphoinositide 3-kinase (PI3K) inhibitors has been evaluated in this study.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"7c792200620fb6321862bfb25d6f45823cf804ed908e80aa410b78963a280ba0","category":"Environment"}